Amber Van Laar

Amber Van Laar is a senior vice president of Global Clinical Development at AskBio, where she is involved in advancing innovative therapies for neurological conditions, including Parkinson's disease. With extensive experience in clinical research, she focuses on developing novel treatments aimed at halting disease progression and improving the quality of life for patients living with Parkinson's.